Found: 13
Select item for more details and to access through your institution.
Real-World Experience With Maribavir for Treatment of Cytomegalovirus Infection in High-Risk Solid Organ Transplant Recipients.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 7, p. 1, doi. 10.1093/ofid/ofae335
- By:
- Publication type:
- Article
Explaining the "Unexpectedly High" Frequency of Invasive Fungal Disease in a Cohort Study of Solid Organ Transplant Recipients Treated With Belatacept.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 6, p. 1, doi. 10.1093/ofid/ofae291
- By:
- Publication type:
- Article
Delayed Mortality Among Solid Organ Transplant Recipients Hospitalized for COVID-19.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 3, p. 711, doi. 10.1093/cid/ciac159
- By:
- Publication type:
- Article
Serial Quantitation of Plasma Microbial Cell-Free DNA Before and After Diagnosis of Pulmonary Invasive Mold Infections After Hematopoietic Cell Transplant.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 2, p. 576, doi. 10.1093/infdis/jiad255
- By:
- Publication type:
- Article
A practical guide to real‐world implementation of pre‐emptive therapy for Cytomegalovirus disease prevention in high‐risk seronegative liver transplant recipients with seropositive donors.
- Published in:
- Transplant Infectious Disease, 2024, v. 26, n. 3, p. 1, doi. 10.1111/tid.14229
- By:
- Publication type:
- Article
The devil is in the details: Nuances of pre‐emptive therapy for cytomegalovirus disease prevention in high‐risk seropositive donors liver transplant recipients.
- Published in:
- Transplant Infectious Disease, 2024, v. 26, n. 3, p. 1, doi. 10.1111/tid.14234
- By:
- Publication type:
- Article
Maribavir versus investigator assigned therapy: Exploring the exploratory.
- Published in:
- Transplant Infectious Disease, 2023, v. 25, n. 3, p. 1, doi. 10.1111/tid.14063
- By:
- Publication type:
- Article
Real‐world effectiveness of preemptive therapy (PET) for cytomegalovirus (CMV) disease prevention in CMV high‐risk donor seropositive/recipient seronegative (D+R‐) liver transplant recipients (LTxR).
- Published in:
- Transplant Infectious Disease, 2023, v. 25, n. 2, p. 1, doi. 10.1111/tid.14015
- By:
- Publication type:
- Article
Combined assessment of Epstein–Barr virus viral capsid antigen and Epstein–Barr virus nuclear antigen‐1 serology for post‐transplant lymphoproliferative disorder risk stratification in adult solid organ transplant recipients.
- Published in:
- Transplant Infectious Disease, 2022, v. 24, n. 6, p. 1, doi. 10.1111/tid.13933
- By:
- Publication type:
- Article
Immunosuppression in solid organ transplant recipients with Covid‐19: More data, but still complicated.
- Published in:
- Transplant Infectious Disease, 2021, v. 23, n. 4, p. 1, doi. 10.1111/tid.13650
- By:
- Publication type:
- Article
Treatment of multidrug‐resistant gram‐negative bacilli after solid organ transplant: Outcomes and complications.
- Published in:
- Transplant Infectious Disease, 2021, v. 23, n. 1, p. 1, doi. 10.1111/tid.13474
- By:
- Publication type:
- Article
Pre‐ and post‐transplant bacterial infections in liver transplant recipients.
- Published in:
- Transplant Infectious Disease, 2019, v. 21, n. 5, p. 1, doi. 10.1111/tid.13152
- By:
- Publication type:
- Article
Healthcare resource use among solid organ transplant recipients hospitalized with COVID‐19.
- Published in:
- Clinical Transplantation, 2021, v. 35, n. 2, p. 1, doi. 10.1111/ctr.14174
- By:
- Publication type:
- Article